GLP-1 Demand Drives Functional Bakery Innovation; Neuroscience Guides Acceptance
Functional bread concepts, led by Millbo, target evolving consumer demand for high-protein, high-fibre staples influenced by GLP-1 medications. Neuroscience insights are crucial for ensuring product acceptance and repeat purchase in this evolving market.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Italian bakery ingredient specialist Millbo is addressing a significant market shift, capitalising on GLP-1 medication's influence on consumer eating habits. The company is developing functional bread ingredient solutions designed for nutrient-dense bakery products. This initiative reflects a broader industry trend where manufacturers are re-evaluating staple foods to deliver enhanced nutritional value without compromising traditional appeal. According to Alessandro Boggiani, Millbo's group chairman, GLP-1 medications have rapidly altered conversations around appetite and food choices, impacting not only users but also a wider consumer base seeking higher protein, more fibre, and fewer 'empty calories'.
Millbo's approach prioritises balancing functionality with taste, texture, and clean label expectations. The company is working on formulations that address common challenges in high-protein/fibre inclusion, such as altered dough behaviour and off-notes from pulses, leveraging fermentation and sprouting to mitigate sensory issues. This strategy enables manufacturers to elevate nutritional profiles while adhering to consumer demands for simpler ingredient lists and avoiding ultra-processed foods (UPFs).
The market opportunity extends beyond niche health products, focusing on everyday formats like sliced bread, wraps, and rolls. Millbo believes this innovation helps keep staples relevant for both GLP-1 users and a wider demographic seeking improved nutritional quality. This focus on making familiar foods more purposeful, rather than simply smaller or lower in calories, is seen as key to sustained market relevance as GLP-1's influence is considered a lasting trend reshaping consumer expectations.
What this means for United Kingdom
UK supplement manufacturers and brand owners should recognise the direct implications of GLP-1 driven dietary shifts, particularly the increased consumer expectation for protein and fibre in staple foods. This necessitates a strategic review of existing product portfolios, identifying reformulation opportunities for higher protein and fibre inclusion, potentially using ingredients like pulse flours or alternative proteins. Procurement teams must anticipate rising demand and potentially higher MOQs for these functional ingredients, impacting raw material costs by 10-20%. Brands have a critical opportunity to launch new, nutrient-dense products, positioning them for satiety and health to capture market share from consumers influenced by GLP-1 trends, with Boots and Holland & Barrett likely key retail channels for such innovations.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.